SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.60    1.80 (1.18%)
Bid:
154.60
Ask:
155.00
Spread: 0.40 (0.259%)
Market Cap: £884.80m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Statement

24 Jun 2015 07:00

RNS Number : 0217R
Elementis PLC
24 June 2015
 



Elementis plc - Trading update

 

Elementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its interim results for the half year ending 30 June 2015, which will be announced on 28 July 2015.

 

Specialty Products continues to make solid progress in terms of leveraging its strong market positions and geographic diversity, and developing new and innovative products to solve our customers' formulary challenges. Market share and contribution margins have remained stable and trading in the first half of the year is anticipated to be in line with management's expectations in most of our key markets. However, temporary market dynamics experienced in the second quarter of the year will most likely negatively influence our full year result.

 

· As recent commentary from the oil sector confirms, there has been a further significant reduction in oil projects in North America and therefore drilling activity has been further curtailed. As a result, we now expect our sales of additives for the first half and the year as a whole to the oilfield drilling market to be at least 30 per cent lower than the previous year, driven by lower volumes.

 

· In coatings additives, the Group continues to make good progress in North America, where the uptake of the new additives line for decorative coatings from our New Martinsville facility is continuing to gain traction with customers. Sales to Latin America have also been robust, based on synergy projects from the previously acquired Watercryl business. In Europe, where underlying economic activity still remains subdued, Group sales for the first half of the year, on a constant currency basis, are expected to be ahead of the same period last year. However, additives sales in China have experienced a reduction in demand during the second quarter of the year and, while the Group still expects sales to be ahead of prior year for the year as a whole, Asia Pacific sales in the first half will be similar to the same period last year. Consequently, overall sales of coatings additives for the first six months of the year, on a constant currency basis, are expected to be at a similar level to the same period last year.

 

· In personal care, the business continues to expand through new product sales and investments into new geographies. However, sales in Latin America have been impacted by significant local currency weakness. This has resulted in the business opting to cease supplying to a number of applications where returns have fallen below an acceptable threshold. The business is taking decisive action to address this competitive dynamic and market share gains from new product introductions have helped to offset the Latin America shortfall. Therefore, sales for the first half will be similar to the strong 2014 first half results. Additionally, positive trends in other markets and geographies mean that full year sales, on a constant currency basis, are expected to be ahead of the previous year.

 

In Chromium, the market trends outlined in the Group's Interim Management Statement in April have continued through the balance of the first half of the year. As such, management expects the operating profit for the full year to be in line with the stated strategy for the business of "stable earnings and cash flow" and the first half result to be similar to the same period last year.

 

The Group's balance sheet remains in a strong position and is expected to show a net cash position at the end of the current year. While the Group remains confident in continuing to make progress in the medium term, the cumulative impact of short term issues arising during the second quarter, as described above, is that earnings per share for the full year are anticipated to be below the current range of market expectations.

 

 

ENDS

 

Enquiries:

Elementis + 44 (0) 207 408 9300

David Dutro, Chief Executive

Brian Taylorson, Finance Director

  

FTI Consulting

 

 

+ 44 (0) 203 727 1000

Deborah Scott

Matthew Cole

  

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFJMPTMBATBIA
Date   Source Headline
11th Jul 20255:32 pmRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20256:04 pmRNSTransaction in Own Shares
8th Jul 20255:27 pmRNSTransaction in Own Shares
7th Jul 20255:54 pmRNSTransaction in Own Shares
4th Jul 20255:30 pmRNSTransaction in Own Shares
3rd Jul 20256:05 pmRNSTransaction in Own Shares
2nd Jul 20255:49 pmRNSTransaction in Own Shares
1st Jul 20255:42 pmRNSTransaction in Own Shares
30th Jun 20256:02 pmRNSTransaction in Own Shares
27th Jun 20255:51 pmRNSTransaction in Own Shares
26th Jun 20255:55 pmRNSTransaction in Own Shares
25th Jun 20255:49 pmRNSTransaction in Own Shares
24th Jun 20255:52 pmRNSTransaction in Own Shares
23rd Jun 20255:31 pmRNSTransaction in Own Shares
20th Jun 20256:22 pmRNSTransaction in Own Shares
18th Jun 20256:06 pmRNSTransaction in Own Shares
17th Jun 20255:43 pmRNSTransaction in Own Shares
16th Jun 20256:07 pmRNSTransaction in Own Shares
13th Jun 20255:53 pmRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20255:38 pmRNSTransaction in Own Shares
10th Jun 20255:33 pmRNSTransaction in Own Shares
10th Jun 20253:49 pmRNSDirector/PDMR Shareholding
10th Jun 20253:48 pmRNSDirector/PDMR Shareholding
9th Jun 20256:19 pmRNSTransaction in Own Shares
6th Jun 20255:10 pmRNSTransaction in Own Shares
5th Jun 20255:54 pmRNSTransaction in Own Shares
4th Jun 20255:56 pmRNSTransaction in Own Shares
3rd Jun 20255:55 pmRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSCommencement of Share Buyback
27th May 20257:00 amRNSSale of Talc business and intended buyback launch
7th May 20254:55 pmRNSHolding(s) in Company
1st May 202510:20 amRNSTotal Voting Rights
29th Apr 202512:24 pmRNSResult of AGM
29th Apr 20257:00 amRNSFirst quarter trading update
25th Mar 20254:22 pmRNSAnnual Financial Report & Notice of AGM
18th Mar 20254:22 pmRNSHolding(s) in Company
18th Mar 20253:10 pmRNSAdditional Listing
13th Mar 20257:00 amRNSAppointment of new Chief Executive Officer
6th Mar 20257:00 amRNSPreliminary results year ended 31 December 2024
3rd Mar 20259:41 amRNSBlock listing Interim Review
3rd Mar 20259:31 amRNSTotal Voting Rights
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.